2015 annual financial data

Supernus Pharmaceuticals, Inc. 2015 Operating margin

Supernus Pharmaceuticals, Inc. 2015 operating margin with verified reported val…

Direct answer

Operating margin was 12.23%.

Operating income was 17,665,000 USD and net income was 14,016,000 USD.
Operating cash flow was 32,123,000 USD.

Get free Supernus Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
144,427,000 USD
Operating income
17,665,000 USD
Net income
14,016,000 USD
Operating cash flow
32,123,000 USD